Copyright
©2013 Baishideng Publishing Group Co.
World J Gastrointest Oncol. Jul 15, 2013; 5(7): 159-170
Published online Jul 15, 2013. doi: 10.4251/wjgo.v5.i7.159
Published online Jul 15, 2013. doi: 10.4251/wjgo.v5.i7.159
Gross type | |
Sclerosing | 10 (34.5) |
Nodular | 8 (27.6) |
Nodular-sclerosing | 6 (20.7) |
Papillary | 2 (6.9) |
Papillary-nodular | 2 (6.9) |
Papillary-sclerosing | 1 (3.4) |
BilIN | |
BilIN-1 and/or 2 | 10 (34.5) |
BilIN-1 | 9 (31) |
BilIN-2 | 5 (17.2) |
BilIN-3 (in situ carcinoma) | 6 (20.7) |
Lymphatic invasion (L1) | 9 (31) |
Venous invasion (V1) | 11 (37.9) |
Perineural invasion | 23 (79.3) |
T-staging (according to AJCC/UICC (7th ed) | |
pTis | 1 (3.4) |
pT1 | 1 (3.4) |
pT2a | 10 (34.5) |
pT2b | 12 (41.4) |
pT3 | 5 (17.2) |
Lymph node status: | |
Positive | 7 (24.1) |
Negative | 16 (55.2) |
No lymph nodes histologically studied | 6 (20.7) |
Margin status | |
Negative (R0) | 12 (41.4) |
Positive (R1) (invasive carcinoma) | 17 (58.6) |
Bile duct margin | 10 (34.5) |
Radial margin | 11 (37.9) |
- Citation: Castellano-Megías VM, Ibarrola-de Andrés C, Colina-Ruizdelgado F. Pathological aspects of so called "hilar cholangiocarcinoma". World J Gastrointest Oncol 2013; 5(7): 159-170
- URL: https://www.wjgnet.com/1948-5204/full/v5/i7/159.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v5.i7.159